Ceridian HCM Holding Inc. (NYSE:CDAY) Shares Acquired by abrdn plc

Posted by Defense World Staff on May 24th, 2023

abrdn plc increased its holdings in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) by 7.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,920 shares of the company’s stock after acquiring an additional 2,583 shares during the quarter. abrdn plc’s holdings in Ceridian HCM were worth $2,433,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Capital International Investors purchased a new stake in shares of Ceridian HCM in the first quarter valued at about $366,250,000. Vanguard Group Inc. grew its stake in shares of Ceridian HCM by 4.1% in the 3rd quarter. Vanguard Group Inc. now owns 16,591,001 shares of the company’s stock valued at $927,105,000 after buying an additional 658,046 shares during the period. Renaissance Technologies LLC increased its holdings in shares of Ceridian HCM by 377.0% during the 1st quarter. Renaissance Technologies LLC now owns 822,000 shares of the company’s stock worth $56,204,000 after buying an additional 649,656 shares during the last quarter. Marshall Wace LLP raised its position in shares of Ceridian HCM by 634.7% during the 3rd quarter. Marshall Wace LLP now owns 381,802 shares of the company’s stock valued at $21,336,000 after buying an additional 329,833 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Ceridian HCM by 2,409.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 324,260 shares of the company’s stock valued at $20,801,000 after acquiring an additional 311,341 shares during the last quarter.

Insider Activity at Ceridian HCM

In other news, EVP Rakesh Subramanian sold 3,692 shares of Ceridian HCM stock in a transaction on Monday, February 27th. The shares were sold at an average price of $72.44, for a total transaction of $267,448.48. Following the completion of the sale, the executive vice president now directly owns 59,444 shares of the company’s stock, valued at approximately $4,306,123.36. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Rakesh Subramanian sold 3,692 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The stock was sold at an average price of $72.44, for a total transaction of $267,448.48. Following the completion of the sale, the executive vice president now owns 59,444 shares in the company, valued at $4,306,123.36. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Leagh Erin Turner sold 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 7th. The shares were sold at an average price of $74.82, for a total value of $448,920.00. Following the completion of the transaction, the chief executive officer now directly owns 245,201 shares of the company’s stock, valued at $18,345,938.82. The disclosure for this sale can be found here. Insiders have sold a total of 36,896 shares of company stock valued at $2,616,959 over the last 90 days. 4.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CDAY shares. Wells Fargo & Company cut their target price on Ceridian HCM from $75.00 to $65.00 in a research note on Thursday, May 4th. Mizuho upped their target price on shares of Ceridian HCM from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, February 9th. Cowen boosted their price target on shares of Ceridian HCM from $77.00 to $87.00 and gave the company an “outperform” rating in a research note on Thursday, February 9th. Robert W. Baird upped their price objective on shares of Ceridian HCM from $78.00 to $86.00 and gave the stock an “outperform” rating in a report on Friday, February 10th. Finally, TheStreet upgraded shares of Ceridian HCM from a “d+” rating to a “c-” rating in a report on Friday, February 10th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $78.79.

Ceridian HCM Price Performance

CDAY stock opened at $62.88 on Wednesday. The business’s 50-day moving average is $65.56 and its two-hundred day moving average is $67.41. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market capitalization of $9.63 billion, a P/E ratio of -262.00 and a beta of 1.44. Ceridian HCM Holding Inc. has a 1 year low of $43.23 and a 1 year high of $79.66.

Ceridian HCM Company Profile

(Get Rating)

Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.